Inhibitors of T-cell activation
US11028170B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2017 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Sep 26, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a bispecific biologic comprising a ligand specific for CTLA-4 and a ligand specific for a pMHC complex.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.